1. Home
  2. ITGR vs HAE Comparison

ITGR vs HAE Comparison

Compare ITGR & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITGR
  • HAE
  • Stock Information
  • Founded
  • ITGR 1970
  • HAE 1971
  • Country
  • ITGR United States
  • HAE United States
  • Employees
  • ITGR N/A
  • HAE N/A
  • Industry
  • ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • HAE Medical/Dental Instruments
  • Sector
  • ITGR Health Care
  • HAE Health Care
  • Exchange
  • ITGR Nasdaq
  • HAE Nasdaq
  • Market Cap
  • ITGR 2.6B
  • HAE 2.5B
  • IPO Year
  • ITGR 2000
  • HAE 1991
  • Fundamental
  • Price
  • ITGR $67.97
  • HAE $68.35
  • Analyst Decision
  • ITGR Buy
  • HAE Strong Buy
  • Analyst Count
  • ITGR 8
  • HAE 9
  • Target Price
  • ITGR $93.14
  • HAE $79.67
  • AVG Volume (30 Days)
  • ITGR 1.9M
  • HAE 876.4K
  • Earning Date
  • ITGR 10-23-2025
  • HAE 11-06-2025
  • Dividend Yield
  • ITGR N/A
  • HAE N/A
  • EPS Growth
  • ITGR N/A
  • HAE 42.52
  • EPS
  • ITGR 2.42
  • HAE 3.44
  • Revenue
  • ITGR $1,831,074,000.00
  • HAE $1,327,850,000.00
  • Revenue This Year
  • ITGR $9.69
  • HAE N/A
  • Revenue Next Year
  • ITGR $0.48
  • HAE $6.35
  • P/E Ratio
  • ITGR $28.15
  • HAE $19.90
  • Revenue Growth
  • ITGR 9.54
  • HAE N/A
  • 52 Week Low
  • ITGR $62.00
  • HAE $47.32
  • 52 Week High
  • ITGR $146.36
  • HAE $94.99
  • Technical
  • Relative Strength Index (RSI)
  • ITGR 27.69
  • HAE 85.05
  • Support Level
  • ITGR $66.00
  • HAE $49.96
  • Resistance Level
  • ITGR $70.16
  • HAE $50.34
  • Average True Range (ATR)
  • ITGR 4.20
  • HAE 2.01
  • MACD
  • ITGR -0.94
  • HAE 1.91
  • Stochastic Oscillator
  • ITGR 11.94
  • HAE 86.51

About ITGR Integer Holdings Corporation

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: